• A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge (Collatamp®G) in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection
  
  
• AtriCure Synergy Bipolar RF Energy Lesions for Permanent Atrial Fibrillation Treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery (ABLATE)
  
  
• A Randomized, Double-blind, Multi-center Study of the Safety and Efficacy of RX 3341 compared with Cefazolin for the Prevention of Surgical Site Infections following Coronary Artery Bypass Graft Surgery (RX-3341)
  
  
• Thoracoscopically-assisted epicardial bilateral Pulmonary Vein isolation using AtriCure bipolar system and exclusion of the Left Atrial Appendage for the treatment of Atrial Fibrillation
  (RESTORE-SR II Trial) (closed to enrollment)
  
  
• TEG During Coronary Artery Bypass Surgery (Adult)
  
  
• TEG During Pediatric Cardiac Surgery
  
  
• Hemodynamic Performance of the Medtronic MOSAIC ULTRA BIOPROSTHESIS
  
  
• Investigation of Arterial Pressure based Cardiac Output in Patients with High Pulse Pressures (APCO)
  
  
• Single Center, Prospective, Randomized, Blinded Evaluator Trial to Determine the Effect of Cormatrix Pericardial Patch on In Vivo Remodeling and Reducing Adhesions in Pediatric Cardiac Surgery Patients with a Planned or Anticipated Re-operation
  
  
• The REVIVAL Trial: TRanscatheter EndoVascular Implantation of VALves Feasibility Study –Transfemoral and Transapical Approaches. The Cribier-Edwards Aortic Bioprosthesis (Transcatheter Heart Valve)
  
  
• THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valves Trial: Edwards SAPIEN™ Transcatheter Heart Valve
  
  
• Visual Interpretation of Completeness and Technical Operative Results using Intra-operative Arteriography (VICTORIA)
  
  

CARDIOLOGY

• Stenting and Angioplasty with Protection in Patients at HIgh-Risk for Endarterectomy
  (SAPPHIRE WW)
  
  
• Future REvascularization Evaluation in Patients with Diabetes mellitus: Optimal Management of Multivessel Disease (FREEDOM)
  
  
• SPIRIT III Trial (closed to enrollment)
  
  
• SYNergy between PCI with TAXUS™ and Cardiac Surgery (SYNTAX Trial) (closed to enrollment)
  
  
• A Post-approval Study of the Guidant ACCULINK Stent Systems and ACCUNET Embolic Protection Systems (Carotid RX ACCULINK/RX ACCUNET Post-Approval Trial to Uncover Unanticipated and Rare Events – “CAPTURE 2”)
  

• Carotid Stenting For High Surgical-Risk Patients: Evaluating Outcomes Through the Collection of Clinical Evidence (“CHOICE”)
  
  

CHF/TRANSPLANT

• HF-ACTION- for Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training - Registry (closed to enrollment)
  
  
• Clinical Investigation of the DeBakey VAD® for Bridging Patients to Cardiac Transplantation while Waiting for a Donor Heart (BTT)
  
  
• The Heartmate II LVAS Pivotal Trial

• Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF)
  
  
• CTOT-05 Observational Study of Alloimmunity in Cardiac Transplant Recipients
  
  

THORACIC ONCOLOGY

OTHER

• A 4-week, multicenter, double-blind, randomized, parallel group study to compare the gastrointestinal (GI) safety and tolerability of myfortic® and MMF (Cellcept®) when administered in combination with calcineurin inhibitors (CNI) in renal transplant recipients experiencing gastrointestinal intolerance (MyGAIN)
  

• Upcoming Trials:
  
  SAVE Trilogy Valve - Aortic Valve Trial (Michael Mack, MD)
  ACOSOG 24033
  

Registries

Sympathectomy

Atrial Fibrillation Ablation

Coronary Artery Revascularization Evaluation (CARE) (closed to enrollment)

MISA

Freestyle Valve

Thymectomy